Phibro Animal Health (PAHC) Profit After Tax (2012 - 2026)
Phibro Animal Health's (PAHC) quarterly Profit After Tax came in at $24.0 million in Q1 2026, up 15.06% year-on-year from $20.9 million in Q1 2025, and down 4.32% quarter-over-quarter from $25.1 million in Q4 2025.
Phibro Animal Health (PAHC) Profit After Tax (2012 - 2026) Analysis & Trends
Phibro Animal Health's Profit After Tax history runs 15 years deep, the most recent figure standing at $24.0 million for Q1 2026.
- On a quarterly basis, Profit After Tax rose 15.06% year-over-year to $24.0 million in Q1 2026; TTM through Mar 2026 was $96.9 million, a 357.98% increase from a year earlier, with the FY2025 full-year figure at $48.3 million, up 1897.68% from the prior year.
- Profit After Tax eased to $24.0 million in Q1 2026 per PAHC's latest filing, from $25.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at $30.5 million in Q3 2025 and bottomed at -$7.0 million in Q4 2024.
- The 5-year median for Profit After Tax is $10.0 million (2023), against an average of $11.0 million.
- Across the five-year window, Profit After Tax slumped 380.12% in 2024 and soared 2190.43% in 2025, its largest moves.
- Year by year, Profit After Tax stood at $10.5 million in 2022, then tumbled by 75.99% to $2.5 million in 2023, then slumped by 380.12% to -$7.0 million in 2024, then soared by 456.42% to $25.1 million in 2025, then dropped by 4.32% to $24.0 million in 2026.
- Per Business Quant, the three latest PAHC Profit After Tax figures stand at $24.0 million (Q1 2026), $25.1 million (Q4 2025), and $30.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 24.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.02 Mn |
| Dec 31, 2025 | 25.11 Mn |
| Sep 30, 2025 | 30.52 Mn |
| Jun 30, 2025 | 17.22 Mn |
| Mar 31, 2025 | 20.88 Mn |
| Dec 31, 2024 | -7.05 Mn |
| Sep 30, 2024 | 6.57 Mn |
| Jun 30, 2024 | 752,000.00 |
| Mar 31, 2024 | 8.41 Mn |
| Dec 31, 2023 | 2.52 Mn |
| Sep 30, 2023 | -4.66 Mn |
| Jun 30, 2023 | 11.50 Mn |
| Mar 31, 2023 | 10.04 Mn |
| Dec 31, 2022 | 10.47 Mn |
| Sep 30, 2022 | 5.17 Mn |
| Jun 30, 2022 | 7.49 Mn |
| Mar 31, 2022 | 17.69 Mn |
| Dec 31, 2021 | 10.85 Mn |
| Sep 30, 2021 | -364,000.00 |
| Jun 30, 2021 | 14.94 Mn |